In E0771 tumors, anti-VEGF treatment significantly increased the percentage of pericyte coverage in tumor microvessels, whereas imatinib ablated pericyte association with tumor vessels (Fig. 1f–h). The gene discussed is VEGFA; the disease is neoplasm.